216 related articles for article (PubMed ID: 19536297)
21. Genetic modulation of hypoxia induced gene expression and angiogenesis: relevance to brain tumors.
Brat DJ; Kaur B; Van Meir EG
Front Biosci; 2003 Jan; 8():d100-16. PubMed ID: 12456339
[TBL] [Abstract][Full Text] [Related]
22. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R
Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841
[TBL] [Abstract][Full Text] [Related]
23. Hypoxia upregulates HIG2 expression and contributes to bevacizumab resistance in glioblastoma.
Mao XG; Wang C; Liu DY; Zhang X; Wang L; Yan M; Zhang W; Zhu J; Li ZC; Mi C; Tian JY; Hou GD; Miao SY; Song ZX; Li JC; Xue XY
Oncotarget; 2016 Jul; 7(30):47808-47820. PubMed ID: 27329597
[TBL] [Abstract][Full Text] [Related]
24. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
[TBL] [Abstract][Full Text] [Related]
25. Recurrence of glioblastoma after radio-chemotherapy is associated with an angiogenic switch to the CXCL12-CXCR4 pathway.
Tabouret E; Tchoghandjian A; Denicolai E; Delfino C; Metellus P; Graillon T; Boucard C; Nanni I; Padovani L; Ouafik L; Figarella-Branger D; Chinot O
Oncotarget; 2015 May; 6(13):11664-75. PubMed ID: 25860928
[TBL] [Abstract][Full Text] [Related]
26. A cDNA-microarray analysis of camptothecin resistance in glioblastoma cell lines.
Morandi E; Zingaretti C; Chiozzotto D; Severini C; Semeria A; Horn W; Vaccari M; Serra R; Silingardi P; Colacci A
Cancer Lett; 2006 Jan; 231(1):74-86. PubMed ID: 16356833
[TBL] [Abstract][Full Text] [Related]
27. Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecan.
Sathornsumetee S; Cao Y; Marcello JE; Herndon JE; McLendon RE; Desjardins A; Friedman HS; Dewhirst MW; Vredenburgh JJ; Rich JN
J Clin Oncol; 2008 Jan; 26(2):271-8. PubMed ID: 18182667
[TBL] [Abstract][Full Text] [Related]
28. Analysis of angiogenesis related factors in glioblastoma, peritumoral tissue and their derived cancer stem cells.
D'Alessio A; Proietti G; Lama G; Biamonte F; Lauriola L; Moscato U; Vescovi A; Mangiola A; Angelucci C; Sica G
Oncotarget; 2016 Nov; 7(48):78541-78556. PubMed ID: 27705944
[TBL] [Abstract][Full Text] [Related]
29. Microarray analysis of tumor necrosis factor alpha induced gene expression in U373 human glioblastoma cells.
Schwamborn J; Lindecke A; Elvers M; Horejschi V; Kerick M; Rafigh M; Pfeiffer J; Prüllage M; Kaltschmidt B; Kaltschmidt C
BMC Genomics; 2003 Nov; 4(1):46. PubMed ID: 14641910
[TBL] [Abstract][Full Text] [Related]
30. Isolinderalactone suppresses human glioblastoma growth and angiogenic activity in 3D microfluidic chip and in vivo mouse models.
Park JH; Kim MJ; Kim WJ; Kwon KD; Ha KT; Choi BT; Lee SY; Shin HK
Cancer Lett; 2020 May; 478():71-81. PubMed ID: 32173479
[TBL] [Abstract][Full Text] [Related]
31. Basic Gene Expression Characteristics of Glioma Stem Cells and Human Glioblastoma.
Sakamoto D; Takagi T; Fujita M; Omura S; Yoshida Y; Iida T; Yoshimura S
Anticancer Res; 2019 Feb; 39(2):597-607. PubMed ID: 30711935
[TBL] [Abstract][Full Text] [Related]
32. Insulin-like growth factor binding protein-4 (IGFBP-4) is a novel anti-angiogenic and anti-tumorigenic mediator secreted by dibutyryl cyclic AMP (dB-cAMP)-differentiated glioblastoma cells.
Moreno MJ; Ball M; Andrade MF; McDermid A; Stanimirovic DB
Glia; 2006 Jun; 53(8):845-57. PubMed ID: 16586492
[TBL] [Abstract][Full Text] [Related]
33. Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironment.
Jeanmougin M; Håvik AB; Cekaite L; Brandal P; Sveen A; Meling TR; Ågesen TH; Scheie D; Heim S; Lothe RA; Lind GE
Mol Oncol; 2020 May; 14(5):1016-1027. PubMed ID: 32171051
[TBL] [Abstract][Full Text] [Related]
34. Analysis of Hypoxia and the Hypoxic Response in Tumor Xenografts.
Böğürcü N; Seidel S; Garvalov BK; Acker T
Methods Mol Biol; 2018; 1742():283-300. PubMed ID: 29330809
[TBL] [Abstract][Full Text] [Related]
35. Angiogenesis and expression of PDGF-C, VEGF, CD105 and HIF-1α in human glioblastoma.
Clara CA; Marie SK; de Almeida JR; Wakamatsu A; Oba-Shinjo SM; Uno M; Neville M; Rosemberg S
Neuropathology; 2014 Aug; 34(4):343-52. PubMed ID: 24612214
[TBL] [Abstract][Full Text] [Related]
36. Targeting Hypoxia-Inducible Factor 1α in a New Orthotopic Model of Glioblastoma Recapitulating the Hypoxic Tumor Microenvironment.
Nigim F; Cavanaugh J; Patel AP; Curry WT; Esaki S; Kasper EM; Chi AS; Louis DN; Martuza RL; Rabkin SD; Wakimoto H
J Neuropathol Exp Neurol; 2015 Jul; 74(7):710-22. PubMed ID: 26083570
[TBL] [Abstract][Full Text] [Related]
37. Cycling hypoxia induces chemoresistance through the activation of reactive oxygen species-mediated B-cell lymphoma extra-long pathway in glioblastoma multiforme.
Chen WL; Wang CC; Lin YJ; Wu CP; Hsieh CH
J Transl Med; 2015 Dec; 13():389. PubMed ID: 26711814
[TBL] [Abstract][Full Text] [Related]
38. Decrease of Nibrin expression in chronic hypoxia is associated with hypoxia-induced chemoresistance in some brain tumour cells.
Cowman S; Fan YN; Pizer B; Sée V
BMC Cancer; 2019 Apr; 19(1):300. PubMed ID: 30943920
[TBL] [Abstract][Full Text] [Related]
39. Glioblastoma-derived Macrophage Colony-stimulating Factor (MCSF) Induces Microglial Release of Insulin-like Growth Factor-binding Protein 1 (IGFBP1) to Promote Angiogenesis.
Nijaguna MB; Patil V; Urbach S; Shwetha SD; Sravani K; Hegde AS; Chandramouli BA; Arivazhagan A; Marin P; Santosh V; Somasundaram K
J Biol Chem; 2015 Sep; 290(38):23401-15. PubMed ID: 26245897
[TBL] [Abstract][Full Text] [Related]
40. AGR2 expression is regulated by HIF-1 and contributes to growth and angiogenesis of glioblastoma.
Hong XY; Wang J; Li Z
Cell Biochem Biophys; 2013; 67(3):1487-95. PubMed ID: 23712868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
